Variant report
Variant | nsv1017567 |
---|---|
Chromosome Location | chr4:158561111-158591903 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:158564345..158567387-chr4:158569401..158572214,3 | MCF-7 | breast: | |
2 | chr4:158564345..158567387-chr4:158569401..158572214,3 | MCF-7 | breast: | |
3 | chr4:158578546..158581523-chr4:158583240..158586033,2 | K562 | blood: | |
4 | chr4:158578546..158581523-chr4:158583240..158586033,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs561640652 | chr4:158574257-158574258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs181544522 | chr4:158574269-158574270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs6821900 | chr4:158574310-158574311 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs560767474 | chr4:158574320-158574321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs138974802 | chr4:158574357-158574358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs2172016 | chr4:158574372-158574373 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs1473501 | chr4:158574381-158574382 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs531644936 | chr4:158574430-158574431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs186281774 | chr4:158574439-158574440 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs568077609 | chr4:158574504-158574505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs535773421 | chr4:158574587-158574588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs547351667 | chr4:158574588-158574589 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs565912244 | chr4:158574608-158574609 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs1844645 | chr4:158574620-158574621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs1844644 | chr4:158574621-158574622 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs557938693 | chr4:158574642-158574643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs4093461 | chr4:158574670-158574671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs576227114 | chr4:158574682-158574683 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs4093460 | chr4:158574691-158574692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs537109940 | chr4:158574714-158574715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs191004631 | chr4:158574724-158574725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs149472141 | chr4:158574771-158574772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs570206137 | chr4:158574794-158574795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs78910091 | chr4:158574814-158574815 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs200253819 | chr4:158574830-158574831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs542559573 | chr4:158574847-158574848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs4691429 | chr4:158574860-158574861 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs202151155 | chr4:158574863-158574864 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs35298661 | chr4:158574909-158574910 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs572662239 | chr4:158574917-158574918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs546081151 | chr4:158574930-158574931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs564309576 | chr4:158574966-158574967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs573998992 | chr4:158574980-158574981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs531704874 | chr4:158574988-158574989 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs549845820 | chr4:158574989-158574990 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs561773941 | chr4:158575004-158575005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs529269017 | chr4:158575059-158575060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs567316286 | chr4:158575067-158575068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs4124427 | chr4:158575167-158575168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs565839100 | chr4:158575192-158575193 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs368540605 | chr4:158575249-158575250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs377705764 | chr4:158575317-158575318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs563005695 | chr4:158575318-158575319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs551618440 | chr4:158575338-158575339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs531790770 | chr4:158575361-158575362 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs534723485 | chr4:158575362-158575363 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs201853052 | chr4:158575384-158575385 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs148234881 | chr4:158575386-158575387 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs112071515 | chr4:158575388-158575389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs398064179 | chr4:158575390-158575391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 16272173 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 20409316 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 20164919 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Melanoma | 17363583 | CNVD |
Autism | 20841430 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:158574200-158577400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr4:158575200-158575400 | Enhancers | Brain Hippocampus Middle | brain |
3 | chr4:158575400-158576400 | Weak transcription | Brain Hippocampus Middle | brain |
4 | chr4:158575600-158577400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr4:158576000-158576200 | Enhancers | Brain Anterior Caudate | brain |
6 | chr4:158576000-158577000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr4:158576200-158576600 | Enhancers | H1 Cell Line | embryonic stem cell |
8 | chr4:158576200-158576600 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
9 | chr4:158576200-158576600 | Flanking Active TSS | Brain Anterior Caudate | brain |
10 | chr4:158576200-158576800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
11 | chr4:158576200-158577000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
12 | chr4:158576200-158577000 | Enhancers | Brain Cingulate Gyrus | brain |
13 | chr4:158576200-158577400 | Enhancers | Adipose Nuclei | Adipose |
14 | chr4:158576400-158576800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
15 | chr4:158576400-158576800 | Enhancers | Aorta | Aorta |
16 | chr4:158576400-158576800 | Enhancers | Brain Angular Gyrus | brain |
17 | chr4:158576400-158576800 | Enhancers | Brain Hippocampus Middle | brain |
18 | chr4:158576400-158576800 | Enhancers | Brain Dorsolateral Prefrontal Cortex | brain |
19 | chr4:158576600-158576800 | Enhancers | Brain Anterior Caudate | brain |
20 | chr4:158585400-158586600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
21 | chr4:158585600-158586000 | Enhancers | Muscle Satellite Cultured Cells | -- |
22 | chr4:158585600-158586800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
23 | chr4:158586200-158586600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |